InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-10.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Bailey Jeffrey Allen, Chairman & CEO. Insider active across 2 companies, notably Biodelivery Sciences International INC. Aggregated, 8 reports have been published. Activity tracked since 6 August 2021. The latest transaction was disclosed on 21 November 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
12,135 shares0Common SharesSEC:0001600620-24-000120:0
17,913 sharesCommon StockSEC:0001600620-24-000116:0
105,133 shares0Common StockSEC:0001103021-22-000065:0
5,333 shares0Common StockSEC:0001103021-22-000053:0
53,333 shares0Common StockSEC:0001628280-21-022261:0
53,333 shares0Common StockSEC:0001628280-21-022261
5,567 shares0Common StockSEC:0001103021-21-000076:0
5,567 shares0Common StockSEC:0001103021-21-000076
8 of 8 declarations
About Bailey Jeffrey Allen
Jeffrey Allen Bailey is the Chief Executive Officer of BioDelivery Sciences International Inc. He leads the company with a vision focused on innovation in the life sciences field. His leadership is crucial for BioDelivery's growth, ensuring that the company remains at the forefront of therapeutic advancements.
